CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
192 hedge funds and large institutions have $1.63B invested in Clovis Oncology, Inc. in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
34% less capital invested
Capital invested by funds: $2.47B → $1.63B (-$839M)
37% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 43
Holders
192
Holding in Top 10
4
Calls
$86.3M
Puts
$26.8M
Top Buyers
| 1 | +$29.7M | |
| 2 | +$22M | |
| 3 | +$17.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.4M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$13.9M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$21.9M | |
| 3 | -$14.5M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$11.8M |